ARDT vs. HIMS, OPCH, GH, RDNT, SHC, SGRY, BTSG, PRVA, CON, and WGS
Should you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry.
Ardent Health Partners vs.
Ardent Health Partners (NYSE:ARDT) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking.
Hims & Hers Health received 24 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 86.36% of users gave Ardent Health Partners an outperform vote while only 37.07% of users gave Hims & Hers Health an outperform vote.
Ardent Health Partners presently has a consensus target price of $21.18, indicating a potential upside of 61.32%. Hims & Hers Health has a consensus target price of $37.31, indicating a potential upside of 0.67%. Given Ardent Health Partners' stronger consensus rating and higher possible upside, equities analysts plainly believe Ardent Health Partners is more favorable than Hims & Hers Health.
63.5% of Hims & Hers Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Hims & Hers Health had 24 more articles in the media than Ardent Health Partners. MarketBeat recorded 26 mentions for Hims & Hers Health and 2 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 1.09 beat Hims & Hers Health's score of 0.72 indicating that Ardent Health Partners is being referred to more favorably in the media.
Hims & Hers Health has a net margin of 8.19% compared to Ardent Health Partners' net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Ardent Health Partners' return on equity.
Ardent Health Partners has higher revenue and earnings than Hims & Hers Health.
Summary
Ardent Health Partners and Hims & Hers Health tied by winning 8 of the 16 factors compared between the two stocks.
Get Ardent Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ardent Health Partners Competitors List
Related Companies and Tools
This page (NYSE:ARDT) was last updated on 3/26/2025 by MarketBeat.com Staff
Buy ARDT Stock Free ARDT Stock Alerts